RSS-Feed abonnieren
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/a-1912-5361
Evaluation of Adnexal Masses: The IOTA Concept
Beurteilung von Adnexbefunden: Das IOTA-Konzept![](https://www.thieme-connect.de/media/ultraschall/202206/lookinside/thumbnails/uim-19125361_10-1055-a-1912-5361-1.jpg)
Abstract
Ovarian lesions have a wide range of sonomorphological features with numerous different underlying benign and malignant histologies. Based on the studies conducted by the International Ovarian Tumor Analysis (IOTA) group, ovarian masses can currently be reliably characterized by ultrasound. In the following article, we explain how to use the IOTA terms and definitions and we provide insight into how to safely triage patients with an ovarian mass.
Zusammenfassung
Ovarielle Raumforderungen haben ein breites Spektrum von sonomorphologischer Kriterien, denen zahlreiche verschiedene benigne und maligne Histologien zugrunde liegen. Auf der Grundlage der Studien der International Ovarian Tumor Analysis (IOTA)-Gruppe können diese zuverlässig mittels Ultraschall charakterisiert werden. Im folgenden Artikel erläutern wir die Verwendung der IOTA-Terminologie und -Definitionen und geben einen Einblick in die Triagierung von Patientinnen mit Ovarialbefunden.
Publikationsverlauf
Artikel online veröffentlicht:
11. Oktober 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Timmerman D, Valentin L, Bourne TH. et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500-505 DOI: 10.1046/j.1469-0705.2000.00287.x.
- 2 Engelen MJA, Kos HE, Willemse PHB. et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006; 106: 589-598 DOI: 10.1002/cncr.21616.
- 3 Chan JK, Kapp DS, Shin JY. et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol 2007; 109: 1342-1350 DOI: 10.1097/01.AOG.0000265207.27755.28.
- 4 Andreotti RF, Timmerman D, Strachowski LM. et al. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology 2020; 294: 168-185 DOI: 10.1148/radiol.2019191150.
- 5 Timmerman D, Schwärzler P, Collins WP. et al. Subjective assessment of adnexal masses with the use of ultrasonography: An analysis of interobserver variability and experience. Ultrasound in Obstetrics and Gynecology 1999; 13: 11-16 DOI: 10.1046/j.1469-0705.1999.13010011.x.
- 6 Valentin L. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound in Obstetrics and Gynecology 1999; 14: 273-283 DOI: 10.1046/j.1469-0705.1999.14040273.x.
- 7 Timmerman D, Planchamp F, Bourne T. et al. ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours. Facts Views Vis Obgyn 2021; 13: 107-130 DOI: 10.52054/FVVO.13.2.016.
- 8 Timmerman D, Ameye L, Fischerova D. et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 2010; 341: c6839 DOI: 10.1136/bmj.c6839.
- 9 Ameye L, Timmerman D, Valentin L. et al. Clinically oriented three-step strategy for assessment of adnexal pathology. Ultrasound Obstet Gynecol 2012; 40: 582-591 DOI: 10.1002/uog.11177.
- 10 Timmerman D, Testa AC, Bourne T. et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005; 23: 8794-8801 DOI: 10.1200/JCO.2005.01.7632.
- 11 Van Calster B, Van Hoorde K, Valentin L. et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 2014; 349: g5920 DOI: 10.1136/bmj.g5920.
- 12 Kaijser J, Sayasneh A, van Hoorde K. et al. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update 2014; 20: 449-462 DOI: 10.1093/humupd/dmt059.
- 13 Meys EMJ, Kaijser J, Kruitwagen RFPM. et al. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. Eur J Cancer 2016; 58: 17-29 DOI: 10.1016/j.ejca.2016.01.007.
- 14 Timmerman D, van Calster B, Testa A. et al. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 2016; 214: 424-437 DOI: 10.1016/j.ajog.2016.01.007.
- 15 Araujo KG, Jales RM, Pereira PN. et al. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center. Ultrasound in Obstetrics and Gynecology 2017; 49: 778-783 DOI: 10.1002/uog.15963.
- 16 Szubert S, Wojtowicz A, Moszynski R. et al. External validation of the IOTA ADNEX model performed by two independent gynecologic centers. Gynecologic Oncology 2016; 142: 490-495 DOI: 10.1016/j.ygyno.2016.06.020.